Factors | Asymptomatic | Symptomatic | Total |
---|---|---|---|
OR (95% CI) | OR (95% CI) | OR (95% CI) | |
Age groups (years) | |||
 < 5 | Reference | Reference | Reference |
 5–15 | 0.60 (0.39–0.92)* | 2.58 (0.69–9.66) | 0.66 (0.44–0.98)* |
 15–25 | 0.52 (0.33–0.81)** | 2.88 (0.78–10.59) | 0.60 (0.39–0.90)* |
 25–50 | 0.61 (0.41–0.89)* | 2.24 (0.67–7.52) | 0.69 (0.48–0.99)* |
 Above 50 | 0.54 (0.36–0.83)** | 1.29 (0.33–5.03) | 0.57 (0.38–0.86)** |
Gender | |||
 Female | Reference | Reference | Reference |
 Male | 0.94 (0.75–1.18) | 1.48 (0.85–2.57) | 0.99 (0.80–1.22) |
Clusters | |||
 Cluster 1 (Hard to reach) | Reference | Reference | Reference |
 Cluster 2 (API ≥ 5) | 1.05 (0.75–1.46) | 0.30 (0.16–0.57)**** | 0.59 (0.43–0.83)** |
 Cluster 3 (API 1–4.99) | 0.79 (0.54–1.16) | 0.08 (0.03–0.21)**** | 0.83 (0.62–1.11) |
 Cluster 4 (API 0–1) | 0.01 (0.005–0.026)**** | empty | 0.01 (0.003–0.02)**** |
Round | |||
 1 | Reference | Reference | Reference |
 2 | 1.07 (0.84–1.37) | empty | 0.98 (0.77–1.24) |
 3 | 0.11 (0.07–0.18)**** | 1.17 (0.66–2.09) | 0.27 (0.20–0.37)**** |
Endemicity | |||
 Low | Reference | Reference | Reference |
 Moderate to high | 88.30 (39.35–198.17)**** | omitted | 104.08 (46.43–233.30)**** |